Study of the Effect of SZC on Serum Potassium and Serum Bicarbonate in Patients With Hyperkalemia and Metabolic Acidosis Associated With Chronic Kidney Disease

PHASE3TerminatedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

March 22, 2021

Primary Completion Date

September 14, 2022

Study Completion Date

September 14, 2022

Conditions
HyperkalaemiaMetabolic AcidosisChronic Kidney Disease
Interventions
DRUG

Sodium zirconium cyclosilicate

Investigational medicinal product

DRUG

Placebo

Plabeco comparator

Trial Locations (30)

10461

Research Site, The Bronx

22304

Research Site, Alexandria

23510

Research Site, Norfolk

27103

Research Site, Winston-Salem

28562

Research Site, New Bern

28801

Research Site, Asheville

29306

Research Site, Spartanburg

31904

Research Site, Columbus

33134

Research Site, Coral Gables

35630

Research Site, Florence

37404

Research Site, Chattanooga

38163

Research Site, Memphis

53226

Research Site, Milwaukee

60521

Research Site, Hinsdale

64111

Research Site, Kansas City

75230

Research Site, Dallas

75246

Research Site, Dallas

77384

Research Site, Shenandoah

78258

Research Site, San Antonio

80045

Research Site, Aurora

80230

Research Site, Denver

89128

Research Site, Las Vegas

90242

Research Site, Downey

90280

Research Site, South Gate

91910

Research Site, Chula Vista

92243

Research Site, El Centro

92395

Research Site, Victorville

98004

Research Site, Bellevue

02903

Research Site, Providence

00918

Research Site, San Juan

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY